Chiang H S, Peng H C, Huang T F
Pharmacological Institute, College of Medicine, National Taiwan University, Taipei.
Biochim Biophys Acta. 1994 Dec 30;1224(3):506-16. doi: 10.1016/0167-4889(94)90288-7.
Integrins are a superfamily of cell surface glycoproteins that mediate cell-extracellular matrix (ECM) and cell-cell adhesion. Immunofluorescence microscopy and flow cytometric analysis using anti-integrin mAbs as the primary binding ligands demonstrated that the platelet integrin receptor alpha IIb beta 3, as well as alpha v beta 3, alpha 5 beta 1 and alpha 6 beta 1, are present on the surface of SW-480 human colon adenocarcinoma cells. Monoclonal antibodies (mAbs) against alpha IIb beta 3 and alpha 5 beta 1 inhibited unstimulated basal adhesion to fibronectin by approximately 30% and 40%, respectively. The surface immunoreactivity of tumor cells for alpha IIb beta 3 was enhanced by pretreatment (5 min) with a phorbol ester (12-O-tetradecanoylphorbol-13-acetate (TPA)) or a lipoxygenase metabolite of arachidonic acid, 12-hydroxyeicosatetraenoic acid (12-HETE) in a dose- and time-dependent manner. SW-480 cells possess a large intracellular pool of alpha IIb beta 3, from which the receptor complex translocates to the cell surface following pretreatment with TPA or 12(S)-HETE. This pretreatment enhances adhesion to fibronectin, which is mediated exclusively by alpha IIb beta 3 integrins. Staurosporine was found to block alpha IIb beta 3 up-regulation and enhanced-adhesion. TPA and 12(S)-HETE also facilitated the redistribution of alpha IIb beta 3 during the enhanced-spreading process. Rhodostomin, an Arg-Gly-Asp- (RGD) containing antiplatelet snake venom peptide, was about 400-times more potent than RGDS at inhibiting control, TPA- or 12(S)-HETE-enhanced adhesion of SW-480 cells to fibronectin. The binding of mAbs against alpha IIb beta 3, alpha v beta 3 and alpha 5 beta 1 was inhibited by pretreatment with rhodostomin, suggesting that rhodostomin binds via its RGD sequence to multiple integrin receptors (i.e., alpha IIb beta 3, alpha v beta 3, alpha 5 beta 1) expressed on the SW-480 cell surface, inhibiting cell adhesion to ECM.
整合素是细胞表面糖蛋白的一个超家族,介导细胞与细胞外基质(ECM)以及细胞与细胞之间的黏附。使用抗整合素单克隆抗体作为主要结合配体的免疫荧光显微镜和流式细胞术分析表明,血小板整合素受体αIIbβ3以及αvβ3、α5β1和α6β1存在于SW - 480人结肠腺癌细胞表面。针对αIIbβ3和α5β1的单克隆抗体(mAbs)分别使未刺激的基础状态下对纤连蛋白的黏附抑制了约30%和40%。用佛波酯(12 - O - 十四酰佛波醇 - 13 - 乙酸酯(TPA))或花生四烯酸的脂氧合酶代谢产物12 - 羟基二十碳四烯酸(12 - HETE)预处理(5分钟),可使肿瘤细胞对αIIbβ3的表面免疫反应性呈剂量和时间依赖性增强。SW - 480细胞拥有大量细胞内αIIbβ3池,在用TPA或12(S) - HETE预处理后,受体复合物从该池中转运至细胞表面。这种预处理增强了对纤连蛋白的黏附,而这种黏附完全由αIIbβ3整合素介导。发现星形孢菌素可阻断αIIbβ3的上调和增强的黏附。TPA和12(S) - HETE在增强铺展过程中也促进了αIIbβ3的重新分布。罗豆素是一种含精氨酸 - 甘氨酸 - 天冬氨酸(RGD)的抗血小板蛇毒肽,在抑制SW - 480细胞对纤连蛋白的对照、TPA或12(S) - HETE增强的黏附方面,其效力比RGDS强约400倍。用罗豆素预处理可抑制针对αIIbβ3、αvβ3和α5β1的单克隆抗体的结合,这表明罗豆素通过其RGD序列与SW - 480细胞表面表达的多种整合素受体(即αIIbβ3、αvβ3、α5β1)结合,抑制细胞与ECM的黏附。